NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|589811532|ref|NP_001277151|]
View 

ribosyldihydronicotinamide dehydrogenase [quinone] isoform 2 [Homo sapiens]

Protein Classification

NAD(P)H-dependent oxidoreductase( domain architecture ID 10006206)

NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+

CATH:  3.40.50.360
EC:  1.-.-.-
PubMed:  25372605|7568029
SCOP:  3001217

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 4.11e-41

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


:

Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 137.28  E-value: 4.11e-41
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   5 KVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNlepratdkditgtlsnpevFNYGVETHEAYKQRSLASD 84
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEG-------------------FDPVLSAADFYRDGPLPID 61
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532  85 ITDEQKKVREADLVIFQ--------------------------------------GKLALLSVTTGGTAEMYTKTGVNGD 126
Cdd:COG2249   62 VAAEQELLLWADHLVFQfplwwysmpallkgwidrvltpgfaygygggypggllkGKKALLVVTTGGPEEAYSRLGYGGP 141
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|..
gi 589811532 127 SRYFlwpLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIW 178
Cdd:COG2249  142 IEEL---LFRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 4.11e-41

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 137.28  E-value: 4.11e-41
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   5 KVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNlepratdkditgtlsnpevFNYGVETHEAYKQRSLASD 84
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEG-------------------FDPVLSAADFYRDGPLPID 61
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532  85 ITDEQKKVREADLVIFQ--------------------------------------GKLALLSVTTGGTAEMYTKTGVNGD 126
Cdd:COG2249   62 VAAEQELLLWADHLVFQfplwwysmpallkgwidrvltpgfaygygggypggllkGKKALLVVTTGGPEEAYSRLGYGGP 141
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|..
gi 589811532 127 SRYFlwpLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIW 178
Cdd:COG2249  142 IEEL---LFRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
4-174 2.66e-33

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 117.43  E-value: 2.66e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532    4 KKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNLePRATDKDITGtLSNPEVfnygvetheaykqrslAS 83
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYALFL-PVLDAEDLAD-LTYPQG----------------AA 62
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   84 DITDEQKKVREADLVIFQ---------------------------------------GKLALLSVTTGGTAEMYTKTGVN 124
Cdd:pfam02525  63 DVESEQEELLAADVIVFQfplywfsvpallkgwidrvlragfafkyeeggpggggllGKKVLVIVTTGGPEYAYGKGGYN 142
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 589811532  125 GDS-RYFLWPLqHGTLHFCGFKVLAPQISF-APEIASEEERKGMVAAWSQRL 174
Cdd:pfam02525 143 GFSlDELLPYL-RGILGFCGITDLPPFAVEgTAGPEDEAALAEALERYEERL 193
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
5-184 2.06e-05

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 43.07  E-value: 2.06e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   5 KVLIVYAHQEPKSfngSLKNVAVDELSRQGCTVTVSDLYAmnlepratdkditgtlSNPEVFnygvetheaykqrslaSD 84
Cdd:PRK04930   7 KVLLLYAHPESQD---SVANRVLLKPAQQLEHVTVHDLYA----------------HYPDFF----------------ID 51
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532  85 ITDEQKKVREADLVIFQGKL------ALL---------------------------SV-TTGGTAEMYTKTGVNgdsRY- 129
Cdd:PRK04930  52 IPHEQALLREHDVIVFQHPLytyscpALLkewldrvlsrgfasgpggnalagkywrSViTTGEPESAYRYDGYN---RYp 128
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 589811532 130 ---FLWPLQHgTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQrlqtiWKEEPIP 184
Cdd:PRK04930 129 msdILRPFEL-TAAMCRMHWLSPIIIYWARRQSPEELASHARAYGD-----WLANPLS 180
 
Name Accession Description Interval E-value
MdaB COG2249
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ...
5-178 4.11e-41

Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only];


Pssm-ID: 441850 [Multi-domain]  Cd Length: 190  Bit Score: 137.28  E-value: 4.11e-41
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   5 KVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNlepratdkditgtlsnpevFNYGVETHEAYKQRSLASD 84
Cdd:COG2249    1 KILIIYAHPDPSSFNAALAEAAAEGLEAAGHEVTVHDLYAEG-------------------FDPVLSAADFYRDGPLPID 61
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532  85 ITDEQKKVREADLVIFQ--------------------------------------GKLALLSVTTGGTAEMYTKTGVNGD 126
Cdd:COG2249   62 VAAEQELLLWADHLVFQfplwwysmpallkgwidrvltpgfaygygggypggllkGKKALLVVTTGGPEEAYSRLGYGGP 141
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|..
gi 589811532 127 SRYFlwpLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIW 178
Cdd:COG2249  142 IEEL---LFRGTLGYCGMKVLPPFVLYGVDRSSDEERAAWLERVRELLAALA 190
Flavodoxin_2 pfam02525
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ...
4-174 2.66e-33

Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258.


Pssm-ID: 426816 [Multi-domain]  Cd Length: 193  Bit Score: 117.43  E-value: 2.66e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532    4 KKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNLePRATDKDITGtLSNPEVfnygvetheaykqrslAS 83
Cdd:pfam02525   1 MKILIINAHPRPGSFSSRLADALVEALKAAGHEVTVRDLYALFL-PVLDAEDLAD-LTYPQG----------------AA 62
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   84 DITDEQKKVREADLVIFQ---------------------------------------GKLALLSVTTGGTAEMYTKTGVN 124
Cdd:pfam02525  63 DVESEQEELLAADVIVFQfplywfsvpallkgwidrvlragfafkyeeggpggggllGKKVLVIVTTGGPEYAYGKGGYN 142
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 589811532  125 GDS-RYFLWPLqHGTLHFCGFKVLAPQISF-APEIASEEERKGMVAAWSQRL 174
Cdd:pfam02525 143 GFSlDELLPYL-RGILGFCGITDLPPFAVEgTAGPEDEAALAEALERYEERL 193
PRK04930 PRK04930
glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional
5-184 2.06e-05

glutathione-regulated potassium-efflux system ancillary protein KefG; Provisional


Pssm-ID: 179895 [Multi-domain]  Cd Length: 184  Bit Score: 43.07  E-value: 2.06e-05
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532   5 KVLIVYAHQEPKSfngSLKNVAVDELSRQGCTVTVSDLYAmnlepratdkditgtlSNPEVFnygvetheaykqrslaSD 84
Cdd:PRK04930   7 KVLLLYAHPESQD---SVANRVLLKPAQQLEHVTVHDLYA----------------HYPDFF----------------ID 51
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 589811532  85 ITDEQKKVREADLVIFQGKL------ALL---------------------------SV-TTGGTAEMYTKTGVNgdsRY- 129
Cdd:PRK04930  52 IPHEQALLREHDVIVFQHPLytyscpALLkewldrvlsrgfasgpggnalagkywrSViTTGEPESAYRYDGYN---RYp 128
                        170       180       190       200       210
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 589811532 130 ---FLWPLQHgTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQrlqtiWKEEPIP 184
Cdd:PRK04930 129 msdILRPFEL-TAAMCRMHWLSPIIIYWARRQSPEELASHARAYGD-----WLANPLS 180
PRK09739 PRK09739
NAD(P)H oxidoreductase;
1-49 2.51e-03

NAD(P)H oxidoreductase;


Pssm-ID: 236620 [Multi-domain]  Cd Length: 199  Bit Score: 37.37  E-value: 2.51e-03
                         10        20        30        40
                 ....*....|....*....|....*....|....*....|....*....
gi 589811532   1 MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNLEP 49
Cdd:PRK09739   1 MQSMRIYLVWAHPRHDSLTAKVAEAIHQRAQERGHQVEELDLYRSGFDP 49
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH